The Health Risks of E-cigarettes in Brazil: A Warning.

Jul.31.2024
The Health Risks of E-cigarettes in Brazil: A Warning.
Brazil's health department in Espirito Santo warns of risks associated with e-cigarette use, highlighting potential health dangers and bans in place.

According to Tribunaonline news on July 30th, the Health Department of the state of Espirito Santo in Brazil issued a warning reminding people of the risks associated with using e-cigarette devices. The department emphasized that in Brazil, the production, import, sale, distribution, storage, transportation, and advertising of all e-cigarette devices are prohibited. Additionally, according to regulations established by the Brazilian National Health Surveillance Agency (ANVISA) this year, the use of any e-cigarette devices is also banned in enclosed environments.


The Ministry of Health has issued a warning stating that e-cigarettes are derivatives of tobacco and are related to tobacco dependence, a chronic disease caused by nicotine addiction in tobacco products. Experts believe that these devices may serve as a gateway product for other forms of tobacco use and lead to addiction.


The pulmonary specialist at the metropolitan area regional specialist center (CRE), Kristiane Rocha Moreira Soneghet, expressed.


These devices contain a certain level of nicotine, which could indeed lead people to use other forms of tobacco and maintain a dependence on nicotine, the appealing aroma could also contribute to this habit.


Dr. Christian further pointed out that it is crucial to raise awareness of the dangers of e-cigarettes. Due to the different flavors and smells of e-cigarettes compared to regular cigarettes, particularly among young people, they often perceive them as harmless to health.


This misunderstanding has made it difficult for many people to realize the dangers of e-cigarettes, leading users to be more resistant to quitting e-cigarettes. It is important to understand that most e-cigarettes contain nicotine, and even those without nicotine still have harmful factors. The vapor from e-cigarettes is not just water, as these substances can cause irritation when they come into direct contact with the respiratory system, leading to coughing, bronchitis, or serious acute inflammation, and even causing lung function failure, such as EVALI (e-cigarette-induced lung injury).


E-cigarettes are also related to cardiovascular diseases and coronary heart disease, potentially leading to myocardial infarction and peripheral circulatory system diseases such as thrombosis. In addition, both traditional cigarettes and e-cigarettes contain potential carcinogens.


In the state of Espirito Santo, the supervision of e-cigarettes is carried out jointly by the state health supervision department (VISA), the health department (Sesa), the state consumer protection and defense institute (Procon), the consumer police department, and the state public prosecutor's office (MPES). These departments are conducting educational actions targeting the younger population. Additionally, the public can also submit relevant opinions through the E-OUV system of the state audit office.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

FDA Sued Over Allowing Some Unauthorized Vapes and Nicotine Pouches to Stay on Market
FDA Sued Over Allowing Some Unauthorized Vapes and Nicotine Pouches to Stay on Market
Public health groups, pediatricians and parents sued the U.S. Food and Drug Administration on July 14, 2026, challenging a May enforcement guidance that they say allows unauthorized e-cigarettes and nicotine pouches to remain on the market while applications are under review.
Jul.15
FDA Grants PMTA Authorization to 11 ZYN ULTRA Nicotine Pouches, Bringing Total Authorized Pouches to 43
FDA Grants PMTA Authorization to 11 ZYN ULTRA Nicotine Pouches, Bringing Total Authorized Pouches to 43
The U.S. Food and Drug Administration authorized 11 ZYN ULTRA nicotine pouch products made by Swedish Match USA through the premarket tobacco product application pathway on August 21, 2026. Ten of the authorized products have a labeled nicotine content of 9 mg, while ZYN ULTRA Smooth was authorized at 11 mg. The reviews were conducted through FDA’s nicotine pouch PMTA pilot program. FDA has now authorized 43 nicotine pouch products, including 23 through the pilot.
Aug.24
Product | JT Launches Ploom AURA Glacier White in Japan, Expanding the Device Ecosystem Through Color and Accessories
Product | JT Launches Ploom AURA Glacier White in Japan, Expanding the Device Ecosystem Through Color and Accessories
Japan Tobacco Inc. (JT) has introduced the Ploom AURA Glacier White heated tobacco device in Japan, adding a new color option to the existing Ploom AURA lineup. The device maintains the existing SMART HEATFLOW technology and HEAT SELECT SYSTEM with four heating modes, while expanding the ecosystem through new accessories including front panels, back covers, a car holder and wireless charging covers. The product entered pre-sale in Japan on June 30, 2026, followed by broader retail availability from July 7.
Aug.03
InterTabac 2026: Further Sessions on Regulation, Market Access and Innovation Confirmed; 2FIRSTS to Host China Market Forum
InterTabac 2026: Further Sessions on Regulation, Market Access and Innovation Confirmed; 2FIRSTS to Host China Market Forum
InterTabac 2026 will bring together international experts to discuss European regulation, tax policy, Track & Trace, market access, retail impacts, consumer behavior and innovation. Sessions will also examine Poland’s tobacco-growing perspective and the growing fragmentation of Europe’s tobacco and nicotine market. Media partner 2FIRSTS will host the second “2FIRSTS Connect at InterTabac” on September 16, focusing on developments in China’s tobacco and nicotine industry.
Aug.06
Exclusive Analysis | Smoore H1 Revenue Rises 19.9% Amid Growth Concentration, Profit Pressure and Slowing Momentum
Exclusive Analysis | Smoore H1 Revenue Rises 19.9% Amid Growth Concentration, Profit Pressure and Slowing Momentum
Smoore’s first-half 2026 revenue rose 19.9%, but the results revealed growing structural risks beneath the headline growth. Heat-not-burn contributed about 61% of incremental revenue and remains driven largely by one core customer, while traditional vaping markets diverged, own-brand growth slowed and China enterprise revenue declined further. Gross profit and adjusted profit lagged revenue growth, while second-quarter revenue growth slowed to about 1.9%, putting greater focus on the quality, concentration and sustainability of Smoore’s expansion.
Capital Markets
Aug.20
Philip Morris Romania Executive on Smoke-Free Strategy: How IQOS Spaces Are Moving Beyond Retail to Consumer Connection
Philip Morris Romania Executive on Smoke-Free Strategy: How IQOS Spaces Are Moving Beyond Retail to Consumer Connection
In an interview with Romanian marketing publication IQads, Marek Gębski, Director of Smoke-Free Products at Philip Morris Romania, said IQOS experience spaces are evolving from traditional retail locations into platforms for consumer engagement and brand connection. Through locations such as IQOS Boutique Victoriei, PMI aims to use design, culture and consumer experiences to strengthen communication with adult consumers about smoke-free products. The interview highlights how tobacco companies are expanding smoke-free strategies beyond products toward experiential marketing and consumer relationships.
Aug.11